PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry and Molecular Biology, University of Valencia, Valencia, Spain\', \'Residential Centre for Elderly People, Savia-Requena, Spain\', \'Medical Specialist in Family and Community Medicine, SAMU Service, Hospital of Sagunto, Spain\', \'Royal Academy of Medicine of the Valencian Community, Spain\', \'Institute for Health Research of the University Clinic Hospital (INCLIVA), Spain\', \'Spanish Royal Academy of Sciences, Spain\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2174/1381612826666200811180232
?:hasPublicationType
?:journal
  • Current pharmaceutical design
is ?:pmid of
?:pmid
?:pmid
  • 32787748
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.883
?:rankingScore_hIndex
  • 136
is ?:relation_isRelatedTo_publication of
?:title
  • Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the \'Cytokine Release (Storm) Syndrome\' Caused by SARS-CoV-2?
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32787748>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32787748>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all